Buy-side firms urged to avoid stampede to CCPs

At risk of getting trampled

Buy-side firms should begin testing over-the-counter derivatives clearing services as early as possible to avoid getting trampled in a last-minute stampede, according to senior industry participants at a recent webinar hosted by Risk in New York.

Under the Dodd-Frank Act, standardised OTC derivatives will be required to be traded on swap execution facilities and cleared through central counterparties (CCPs). Regulators are going through a lengthy process of rule-making to implement the changes

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: